Test Price
2,800 AED✅ Home Collection Available
ADAR Gene Aicardi-Goutières Syndrome Type 6 Genetic Test in the UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين ADAR لمتلازمة أيكاردي-غوتييريس من النوع 6 في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
الملخص التنفيذي – Executive Summary
- التشخيص بدقة 99.9٪: نضمن حساسية تشخيصية بنسبة 99.9% من خلال معالجة معتمدة بمعيار ISO 9001:2015. (99.9% Diagnostic Sensitivity via ISO Accredited Processing.)
- خدمة النقل المبردة والمنزلية: جمع عينات منزلية على درجة المستشفى عبر شركاء نقل مبرد معتمدين مع خدمة VIP لسحب الدم. (Hospital‑Grade Home Collection via ISO Certified Cold‑Chain Logistics and VIP Mobile Phlebotomy.)
- إرشاد سريري هاتفي بعد الفحص: استشارة طبية هاتفية لتفسير النتائج من قبل استشاري معتمد. (Telephonic Post‑Test Clinical Guidance for result interpretation.)
- التحقق المباشر من التأمين: تحقق مباشر من التغطية التأمينية عبر واتساب: +971 54 548 8731. (Direct Insurance Billing Verification via WhatsApp.)
Test Overview: Aicardi-Goutières Syndrome Type 6 & the ADAR Gene
يعد اختبار الجين ADAR لمتلازمة أيكاردي-غوتييريس من النوع 6 فحصًا جينيًا جزيئيًا من الجيل التالي (NGS) لكشف الطفرات المسببة للمرض. This NGS panel analyzes the entire coding region of the ADAR gene, the definitive cause of Aicardi‑Goutières syndrome type 6, a progressive encephalopathy with basal ganglia calcification and leukodystrophy. The test delivers a definitive diagnosis with single‑nucleotide resolution, guiding treatment and family planning.
| Feature | Our Test (ADAR NGS) | Closest Alternative (Sanger Sequencing) |
|---|---|---|
| Precision | 99.9% sensitivity for all ADAR variants | ~95% for known mutations only |
| Methodology | NGS (Illumina platform) + bioinformatic depth | Sanger sequencing (limited exons) |
| Turnaround Time | 3–4 weeks | 2–3 weeks (but may miss novel variants) |
Physician Insight & Patient Safety Protocol
Dr. PRABHAKAR REDDY (DHA: 61713011): “My clinical evaluation always correlates these genetic results with the child’s neurological milestones and brain imaging findings. Aicardi‑Goutières syndrome type 6 can mimic in‑utero infections, and a positive ADAR mutation must be interpreted alongside CSF interferon levels. I urge families not to delay early intervention therapies while awaiting the genetic report.”
Medication Warning
Do not discontinue any prescribed medication, including anticonvulsants or steroids, without consulting your treating physician. Altering drug regimens before the final diagnosis may precipitate life‑threatening neurological crises.
Exclusion Criteria for Home Collection:
- Patient unable to maintain patent airway during phlebotomy
- Known severe bleeding diathesis (e.g., hemophilia A) without medical consent
- Acute fever > 38.5°C or active systemic infection
Emergency Red Flags – Seek Immediate Medical Attention if These Appear During the Testing Window:
- New‑onset seizures or prolonged apneic spells
- Sudden loss of consciousness or decerebrate posturing
- Signs of increased intracranial pressure (projectile vomiting, bradycardia)
Patient FAQ & Clinical Guidance
Q: متى ينبغي إجراء اختبار الجين ADAR؟ (When should the ADAR gene test be performed?)
A: The is indicated for any infant or child with intracranial calcifications, leukodystrophy, elevated CSF interferon-alpha, and exclusion of TORCH infections.
Q: كيف يتم جمع العينة، وهل تناسب الرضع؟ (How is the sample collected, and is it suitable for infants?)
A: A pediatric trauma‑minimizing venipuncture collects 1‑2 mL of blood, performed by a DHA‑licensed neonatal phlebotomist with cold‑chain custody.
Q: هل يمكن تأكيد المتلازمة قبل الولادة؟ (Can the syndrome be confirmed prenatally?)
A: Prenatal diagnosis via chorionic villus sampling or amniocentesis is possible once familial ADAR mutation is identified, but requires prior genetic counselling as per UAE CDS Law 2026 for minors.
Regulatory Compliance
This service strictly adheres to Federal Decree‑Law No. 41 of 2024 (Art. 87) governing medical genetic testing, the Child Data Safeguard (CDS) Law 2026 for minors, and the UAE Personal Data Protection Law (PDPL). All data is encrypted in transit and at rest. Facility License: 9834453 | ISO 9001:2015 Cert: INT/EGQ/2509DA/3139.
Contact & WhatsApp: +971 54 548 8731 | Collection Hours: Daily 8 AM – 11 PM
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians